Eli Lilly and Company (LLY)
NYSE: LLY · IEX Real-Time Price · USD
906.71
-7.66 (-0.84%)
At close: Jul 2, 2024, 4:00 PM
910.50
+3.79 (0.42%)
After-hours: Jul 2, 2024, 7:59 PM EDT
Eli Lilly Employees
Eli Lilly and Company had 43,000 employees as of December 31, 2023. The number of employees increased by 4,000 or 10.26% compared to the previous year.
Employees
43,000
Change (1Y)
4,000
Growth (1Y)
10.26%
Revenue / Employee
$835,630
Profits / Employee
$142,753
Market Cap
861.74B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 43,000 | 4,000 | 10.26% |
Dec 31, 2022 | 39,000 | 4,000 | 11.43% |
Dec 31, 2021 | 35,000 | 0 | - |
Dec 31, 2020 | 35,000 | 1,375 | 4.09% |
Dec 31, 2019 | 33,625 | -5,055 | -13.07% |
Dec 31, 2018 | 38,680 | -1,975 | -4.86% |
Dec 31, 2017 | 40,655 | -1,320 | -3.14% |
Dec 31, 2016 | 41,975 | 700 | 1.70% |
Dec 31, 2015 | 41,275 | 2,140 | 5.47% |
Dec 31, 2014 | 39,135 | 1,210 | 3.19% |
Dec 31, 2013 | 37,925 | -425 | -1.11% |
Dec 31, 2012 | 38,350 | 270 | 0.71% |
Dec 31, 2011 | 38,080 | -270 | -0.70% |
Dec 31, 2010 | 38,350 | -2,010 | -4.98% |
Dec 31, 2009 | 40,360 | -140 | -0.35% |
Dec 31, 2008 | 40,500 | -100 | -0.25% |
Dec 31, 2007 | 40,600 | -900 | -2.17% |
Dec 31, 2006 | 41,500 | -1,100 | -2.58% |
Dec 31, 2005 | 42,600 | -1,900 | -4.27% |
Dec 31, 2004 | 44,500 | -1,600 | -3.47% |
Dec 31, 2003 | 46,100 | 2,400 | 5.49% |
Dec 31, 2002 | 43,700 | 2,600 | 6.33% |
Dec 31, 2001 | 41,100 | 5,400 | 15.13% |
Dec 31, 2000 | 35,700 | 4,400 | 14.06% |
Dec 31, 1999 | 31,300 | 1,500 | 5.03% |
Dec 31, 1998 | 29,800 | -1,300 | -4.18% |
Dec 31, 1997 | 31,100 | 1,900 | 6.51% |
Dec 31, 1996 | 29,200 | 2,400 | 8.96% |
Dec 31, 1995 | 26,800 | 1,900 | 7.63% |
Dec 31, 1994 | 24,900 | -7,800 | -23.85% |
Dec 31, 1993 | 32,700 | 500 | 1.55% |
Dec 31, 1992 | 32,200 | 1,400 | 4.55% |
Dec 31, 1991 | 30,800 | 1,300 | 4.41% |
Dec 31, 1990 | 29,500 | 1,700 | 6.12% |
Dec 31, 1989 | 27,800 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
LLY News
- 6 hours ago - Novo Nordisk and Eli Lilly Slide as Biden Blasts Weight-Loss Drug Prices - Investopedia
- 8 hours ago - Eli Lilly's Alzheimer's drug wins FDA approval - Market Watch
- 9 hours ago - FDA Approves Eli Lilly's Alzheimer's Drug Donanemab - Forbes
- 9 hours ago - FDA approves Eli Lilly Alzheimer's drug, expanding treatment options in the U.S. - CNBC
- 9 hours ago - US FDA approves Lilly's Alzheimer's drug - Reuters
- 10 hours ago - Approval of Newest Alzheimer's Drug Will Accelerate New Era of Treatment - WSJ
- 10 hours ago - Lilly's Kisunla™ (donanemab-azbt) Approved by the FDA for the Treatment of Early Symptomatic Alzheimer's Disease - PRNewsWire
- 12 hours ago - Joe Biden Suggests Novo Nordisk, Eli Lilly To Lower Prices For Its Popular Obesity Drugs - Benzinga